Correlation Between Viridian Therapeutics and Teradata Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Teradata Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Teradata Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Teradata Corp, you can compare the effects of market volatilities on Viridian Therapeutics and Teradata Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Teradata Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Teradata Corp.

Diversification Opportunities for Viridian Therapeutics and Teradata Corp

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Viridian and Teradata is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Teradata Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teradata Corp and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Teradata Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teradata Corp has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Teradata Corp go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Teradata Corp

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 1.62 times more return on investment than Teradata Corp. However, Viridian Therapeutics is 1.62 times more volatile than Teradata Corp. It trades about 0.04 of its potential returns per unit of risk. Teradata Corp is currently generating about -0.05 per unit of risk. If you would invest  1,585  in Viridian Therapeutics on August 24, 2024 and sell it today you would earn a total of  429.00  from holding Viridian Therapeutics or generate 27.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy94.88%
ValuesDaily Returns

Viridian Therapeutics  vs.  Teradata Corp

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Teradata Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Teradata Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Teradata Corp may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Viridian Therapeutics and Teradata Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Teradata Corp

The main advantage of trading using opposite Viridian Therapeutics and Teradata Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Teradata Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teradata Corp will offset losses from the drop in Teradata Corp's long position.
The idea behind Viridian Therapeutics and Teradata Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges